0,881  0,002  Antimutagenic
0,873  0,005  Antileukemic
0,869  0,004  Caspase 9 stimulant
0,847  0,003  NOS2 expression inhibitor
0,846  0,011  Apoptosis agonist
0,794  0,004  Free radical scavenger
0,789  0,004  Antioxidant
0,786  0,006  Chemoprotective
0,780  0,003  Monophenol monooxygenase inhibitor
0,790  0,013  Transcription factor NF kappa B inhibitor
0,772  0,004  AR expression inhibitor
0,775  0,021  Alpha-glucosidase inhibitor
0,748  0,013  Antineoplastic (lung cancer)
0,740  0,009  Carcinogenic
0,723  0,009  Chemopreventive
0,715  0,003  Melanin inhibitor
0,697  0,004  Skin whitener
0,698  0,014  TNF expression inhibitor
0,688  0,005  UGT1A1 substrate
0,679  0,008  UGT1A9 substrate
0,670  0,008  CTGF expression inhibitor
0,659  0,005  UDP-glucuronosyltransferase substrate
0,686  0,034  Antiinflammatory
0,642  0,012  Mutagenic
0,641  0,012  Radioprotector
0,646  0,019  Antineoplastic (colorectal cancer)
0,638  0,010  12-Lipoxygenase inhibitor
0,640  0,013  Antineoplastic (ovarian cancer)
0,633  0,008  Lipoxygenase inhibitor
0,640  0,018  Antineoplastic (colon cancer)
0,646  0,028  Antineoplastic (breast cancer)
0,626  0,009  Caspase 3 stimulant
0,614  0,004  Breast cancer-resistant protein inhibitor
0,599  0,005  Hepatoprotectant
0,578  0,005  UGT1A3 substrate
0,582  0,011  Nitric oxide antagonist
0,578  0,012  Antineoplastic (non-small cell lung cancer)
0,569  0,014  Proliferative diseases treatment
0,575  0,022  Aldehyde oxidase inhibitor
0,561  0,013  CYP2C19 inhibitor
0,557  0,012  Antineoplastic (glioma)
0,558  0,015  Cardioprotectant
0,556  0,015  Hepatic disorders treatment
0,565  0,025  Antibacterial
0,556  0,017  Spasmolytic
0,540  0,004  UGT2B15 substrate
0,546  0,011  CYP1A2 inhibitor
0,545  0,017  Histamine release inhibitor
0,546  0,019  CYP1A2 substrate
0,544  0,021  CYP2C19 substrate
0,535  0,013  Antiprotozoal (Leishmania)
0,543  0,022  Antihypercholesterolemic
0,532  0,011  UGT1A6 substrate
0,533  0,024  Streptokinase A inhibitor
0,520  0,012  Antineoplastic (glioblastoma multiforme)
0,521  0,021  GABA C receptor rho-3 antagonist
0,515  0,018  NOS3 expression inhibitor
0,518  0,034  Antiparkinsonian
0,514  0,030  Prostate cancer treatment
0,483  0,005  Pneumotoxic
0,499  0,030  Angiogenesis inhibitor
0,482  0,025  Antineoplastic (cervical cancer)
0,471  0,017  Antiparasitic
0,477  0,024  Sensitization
0,459  0,013  Peroxidase inhibitor
0,451  0,006  Protein-tyrosine phosphatase inhibitor
0,465  0,024  Cytostatic
0,444  0,004  Heat shock protein 90 antagonist
0,479  0,040  CYP2C9 substrate
0,446  0,009  Antiseptic
0,454  0,019  Amyloid beta aggregation inhibitor
0,441  0,009  Genotoxic
0,461  0,029  Antineoplastic (melanoma)
0,428  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,469  0,048  15-Lipoxygenase inhibitor
0,429  0,008  Lipid peroxidase inhibitor
0,425  0,007  NOS3 expression enhancer
0,439  0,026  ICAM1 expression inhibitor
0,417  0,005  Heat shock protein 90 alpha antagonist
0,415  0,004  Xanthine oxidase inhibitor
0,411  0,011  Antihypotensive
0,433  0,039  Respiratory analeptic
0,412  0,025  Tumour necrosis factor alpha release inhibitor
0,414  0,035  Antineoplastic (pancreatic cancer)
0,388  0,017  UGT1A4 substrate
0,363  0,006  NADPH oxidase inhibitor
0,385  0,028  Antihypoxic
0,385  0,034  Hypoxia-inducible factor 1 alpha inhibitor
0,380  0,030  Cardiodepressant
0,364  0,015  UGT2B7 substrate
0,404  0,056  CYP2C9 inhibitor
0,345  0,005  Topoisomerase II alpha inhibitor
0,349  0,009  Sulfotransferase substrate
0,372  0,032  Superoxide dismutase inhibitor
0,375  0,037  UGT2B4 substrate
0,353  0,015  Antineoplastic (squamous cell carcinoma)
0,382  0,044  Antineoplastic (brain cancer)
0,365  0,030  Antineoplastic (liver cancer)
0,358  0,027  Antihypertriglyceridemic
0,399  0,069  Antiprotozoal
0,346  0,017  Antineoplastic (carcinoma)
0,336  0,007  Cystathionine beta-synthase inhibitor
0,341  0,015  Tubulin antagonist
0,371  0,046  Vasodilator, coronary
0,338  0,017  VCAM1 expression inhibitor
0,366  0,052  CYP2D6 substrate
0,364  0,050  Apoptosis antagonist
0,325  0,013  MAO A inhibitor
0,345  0,034  Vasodilator
0,351  0,040  Antipyretic
0,346  0,036  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,338  0,041  Antineoplastic (lymphoma)
0,314  0,019  Carcinogenic, group 3
0,339  0,045  Cytotoxic
0,309  0,017  Topoisomerase II inhibitor
0,323  0,032  Antineoplastic enhancer
0,299  0,011  5-Lipoxygenase inhibitor
0,357  0,069  Antiprotozoal (Plasmodium)
0,298  0,012  Alkaline phosphatase inhibitor
0,325  0,041  Pyruvate kinase inhibitor
0,329  0,050  Antineoplastic (osteosarcoma)
0,295  0,017  Protein kinase stimulant
0,302  0,029  P-glycoprotein inhibitor
0,294  0,021  MAO inhibitor
0,278  0,010  Interleukin 4 antagonist
0,315  0,048  Dyrk kinase inhibitor
0,332  0,067  Antifungal
0,267  0,003  Neuraminidase inhibitor
0,268  0,011  Antihemorrhagic
0,270  0,014  Chelator
0,290  0,034  RNA-directed DNA polymerase inhibitor
0,325  0,074  FMO1 substrate
0,297  0,053  Antineoplastic (renal cancer)
0,298  0,058  DNA damaging
0,310  0,069  Analeptic
0,327  0,088  CYP3A4 substrate
0,260  0,029  Antiviral (Hepatitis)
0,280  0,057  Angiogenesis stimulant
0,241  0,019  Antiviral (Hepatitis B)
0,238  0,018  SULT1A3 substrate
0,231  0,013  SULT1A1 substrate
0,236  0,018  UGT2B10 substrate
0,240  0,023  UGT2B9 substrate
0,235  0,021  Antifungal enhancer
0,229  0,020  Topoisomerase I inhibitor
0,253  0,044  Antihelmintic
0,225  0,018  GABA C receptor rho-2 antagonist
0,273  0,069  Antiprotozoal (Trypanosoma)
0,250  0,049  Platelet adhesion inhibitor
0,213  0,012  Carbonic anhydrase XIII inhibitor
0,231  0,034  Amylase inhibitor
0,265  0,068  Hypoglycemic
0,310  0,114  Antipruritic, allergic
0,287  0,094  Antineoplastic (small cell lung cancer)
0,200  0,008  Beta tubulin antagonist
0,205  0,015  UGT2B1 substrate
0,218  0,028  Acetylcholinesterase inhibitor
0,235  0,053  DNA methyltransferase I inhibitor
0,215  0,033  Antidote
0,194  0,012  Multidrug resistance-associated protein 1 inhibitor
0,202  0,020  CF transmembrane conductance regulator agonist
0,190  0,008  Heat shock protein 70 antagonist
0,322  0,142  5 Hydroxytryptamine release inhibitor
0,262  0,083  Antidiabetic (type 2)
0,227  0,049  CYP2B6 inhibitor
0,321  0,145  Antidiabetic
0,321  0,145  Cyclophilin D inhibitor
0,201  0,026  Cholesterol synthesis inhibitor
0,213  0,040  Succinate dehydrogenase inhibitor
0,287  0,115  Ulceration
0,185  0,014  Papain-like protease (SARS coronavirus) inhibitor
0,186  0,016  Photosensitizer
0,247  0,081  Antineoplastic (bladder cancer)
0,189  0,024  Carcinogenic, group 2B
0,245  0,085  5 Hydroxytryptamine uptake stimulant
0,172  0,013  NAD(P)H dehydrogenase (quinone) inhibitor
0,203  0,046  Antiviral (Herpes)
0,210  0,055  Antipruritic, non-allergic
0,166  0,012  HIV-1 integrase (3'-Processing) inhibitor
0,169  0,018  Beta glucuronidase inhibitor
0,230  0,081  Antiamyloidogenic
0,183  0,036  Neurotrophic factor
0,173  0,026  Antineoplastic antibiotic
0,184  0,041  Cyclooxygenase 1 inhibitor
0,188  0,047  Contraceptive
0,216  0,075  Antimitotic
0,153  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,147  0,007  Xanthine dehydrogenase inhibitor
0,159  0,020  Estrogen antagonist
0,186  0,047  Arachidonic acid antagonist
0,152  0,015  Estrogen receptor beta antagonist
0,205  0,068  Insulin sensitizer
0,177  0,041  M18 aspartyl aminopeptidase inhibitor
0,146  0,011  Aldose reductase inhibitor
0,168  0,034  Gout treatment
0,219  0,086  Teratogen
0,143  0,013  Estrogen receptor alpha antagonist
0,138  0,009  Neuraminidase (influenza) inhibitor
0,161  0,034  MAO B inhibitor
0,147  0,021  Telomerase inhibitor
0,222  0,096  Antineoplastic (sarcoma)
0,177  0,052  Interferon gamma antagonist
0,143  0,018  SULT1E1 substrate
0,155  0,030  Antineoplastic (uterine cancer)
0,198  0,073  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,135  0,011  Alpha tubulin antagonist
0,141  0,019  UGT2B11 substrate
0,196  0,075  Non-steroidal antiinflammatory agent
0,154  0,034  Expectorant
0,226  0,106  Transcription factor STAT inhibitor
0,124  0,005  Potassium channel Kv1.3 blocker
0,142  0,026  DOPA decarboxylase inhibitor
0,203  0,090  Embryotoxic
0,174  0,062  Eye irritation, high
0,145  0,035  TRPA1 agonist
0,149  0,039  Vanilloid 1 agonist
0,178  0,069  Dual specificity phosphatase inhibitor
0,144  0,036  Mucolytic
0,192  0,084  DNA methylase inhibitor
0,180  0,073  LDLR expression enhancer
0,188  0,082  Antiviral (Influenza)
0,151  0,046  Antihelmintic (Trematoda)
0,135  0,031  Electron transport complex I inhibitor
0,178  0,075  Dual specificity phosphatase 3 inhibitor
0,250  0,148  Immunosuppressant
0,167  0,067  Interleukin 6 antagonist
0,126  0,026  Phosphodiesterase 4D inhibitor
0,154  0,056  Adenylate cyclase stimulant
0,131  0,034  Creatine kinase inhibitor
0,147  0,051  Cyclooxygenase 3 inhibitor
0,197  0,102  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,160  0,066  Antiviral (Influenza A)
0,226  0,132  Bone diseases treatment
0,202  0,108  Vascular (periferal) disease treatment
0,099  0,006  Postcoital contraceptive
0,170  0,078  Antineoplastic (bone cancer)
0,229  0,138  Prostaglandin dehydrogenase inhibitor
0,170  0,080  Antineoplastic (gastric cancer)
0,105  0,015  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,096  0,008  Transcription factor RelA inhibitor
0,117  0,028  Ornithine decarboxylase inhibitor
0,158  0,070  Cholinergic
0,149  0,063  Cytokine production inhibitor
0,119  0,033  Protein kinase C zeta inhibitor
0,090  0,004  Retinoic acid alpha receptor agonist
0,208  0,123  Transcription factor STAT3 inhibitor
0,125  0,039  Toll-Like receptor 4 antagonist
0,128  0,043  Butyrylcholinesterase inhibitor
0,121  0,037  Antineoplastic alkaloid
0,136  0,053  Gastritis treatment
0,143  0,061  Farnesoid X receptor antagonist
0,094  0,012  Leukotriene B4 antagonist
0,180  0,098  Neurotrophic factor enhancer
0,119  0,039  Uric acid excretion stimulant
0,101  0,021  Aromatase inhibitor
0,104  0,025  Thioredoxin reductase inhibitor
0,110  0,031  Interleukin 5 antagonist
0,125  0,047  GABA C receptor antagonist
0,188  0,111  Nitric-oxide synthase stimulant
0,101  0,024  SULT1A2 substrate
0,118  0,045  Dementia treatment
0,206  0,133  Radiosensitizer
0,117  0,046  Carbonic anhydrase III inhibitor
0,100  0,030  Keratolytic
0,176  0,107  Antiulcerative
0,113  0,045  Vascular dementia treatment
0,158  0,090  Phospholipase C inhibitor
0,088  0,021  Antidote, heavy metal
0,087  0,021  Estrogen agonist
0,191  0,126  Immunostimulant
0,141  0,078  Cyclooxygenase inhibitor
0,172  0,110  VEGF expression inhibitor
0,094  0,032  Histone deacetylase stimulant
0,094  0,032  Histone deacetylase SIRT1 stimulant
0,096  0,035  D-Ala-D-Ala ligase inhibitor
0,233  0,172  Antineoplastic (endocrine cancer)
0,133  0,073  Bone formation stimulant
0,203  0,145  Antineoplastic (multiple myeloma)
0,096  0,038  Vanilloid agonist
0,114  0,058  Glutathione S-transferase substrate
0,108  0,052  GABA C receptor rho-1 antagonist
0,111  0,055  Carbonic anhydrase XV inhibitor
0,075  0,024  Postmenopausal disorders treatment
0,187  0,137  Antiosteoporotic
0,067  0,018  Glucose-6-phosphate translocase inhibitor
0,083  0,036  HIV-1 integrase inhibitor
0,079  0,032  Leukotriene antagonist
0,176  0,129  Cardiovascular analeptic
0,073  0,028  Maillard reaction inhibitor
0,118  0,072  Antiviral (Influenza B)
0,099  0,056  HIV-1 integrase (Overall Integration) inhibitor
0,089  0,049  Glutathione S-transferase inhibitor
0,081  0,042  Lipase inhibitor
0,056  0,018  Estrogen receptor beta agonist
0,139  0,102  Carcinogenic, group 1
0,057  0,021  Carbonic anhydrase VII inhibitor
0,079  0,044  CDC25A inhibitor
0,065  0,030  Fatty acid synthase inhibitor
0,093  0,058  Thioredoxin inhibitor
0,056  0,021  Estradiol 17 beta-dehydrogenase inhibitor
0,049  0,014  Retinoid X alpha receptor agonist
0,210  0,176  GST A substrate
0,114  0,080  Contraceptive female
0,209  0,176  GST M1-1 substrate
0,101  0,068  Mediator release inhibitor
0,136  0,104  Mcl-1 antagonist
0,084  0,052  Carbonic anhydrase VI inhibitor
0,050  0,018  Retinoid X receptor agonist
0,112  0,080  Aldehyde dehydrogenase inhibitor
0,101  0,072  Skin irritative effect
0,100  0,073  Choleretic
0,046  0,018  Estrogen receptor alpha agonist
0,111  0,084  Alcohol dehydrogenase substrate
0,157  0,130  Aryl hydrocarbon receptor agonist
0,062  0,036  Heat shock protein 90 beta antagonist
0,055  0,029  Vanilloid 2 antagonist
0,104  0,079  Antiviral (SARS coronavirus)
0,104  0,079  Antiviral (Coronavirus)
0,083  0,058  Antiviral (Trachoma)
0,069  0,045  Leukotriene synthesis inhibitor
0,112  0,089  Cyclooxygenase 2 inhibitor
0,074  0,052  Antibiotic
0,031  0,009  Retinoic acid receptor agonist
0,142  0,123  Anesthetic general
0,136  0,118  Amyloid beta precursor protein antagonist
0,092  0,075  Anabolic
0,042  0,030  DNA gyrase subunit A inhibitor
0,188  0,176  Cholesterol antagonist
0,029  0,018  Leukotriene B4 receptor 1 antagonist
0,148  0,137  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,032  0,023  Catechol O-methyltransferase inhibitor
0,191  0,182  FMO3 substrate
0,105  0,097  Toll-Like receptor 2 antagonist
0,031  0,023  ATP citrate lysase inhibitor
0,076  0,070  Antiprotozoal activity enhancer
0,022  0,016  Leukotriene B4 receptor 2 antagonist
0,063  0,058  Histidine decarboxylase inhibitor
0,021  0,017  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,071  0,066  Narcotic antagonist
0,056  0,055  Antimycoplasmal
0,152  0,151  Antiviral (HIV)
0,076  0,076  GST P1-1 substrate

